API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 134 articles Forum Github 13 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. AU /
  3. NEU.AU

Neuren Pharmaceuticals Ltd (NEU AU) stock market data APIs

A$13.65 -0.54(-3.8%) as of September 20, 2024
Price chart is built with Anychart

Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. It develops and commercializes DAYBUE (trofinetide), which has been registered to treat Rett syndrome in adults and pediatric patients 2 years of age and older, as well as in Phase 2 clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591, which has completed Phase 2 clinical trial for the treatment of Phelan-McDermid, and in Phase 2 clinical trial for the treatment of Angelman, Pitt Hopkins, and Prader-Will syndromes. In addition, it provides development services; and holds loan funded shares. The company was incorporated in 2001 and is based in Camberwell, Australia.

Neuren Pharmaceuticals Ltd Financial Data Overview

14.19
13.65
-
15.24
13.63
10.02-25.95
1 853 M
15.3226
130 M
193 M
2.134
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'NEU',
Type: 'Common Stock',
Name: 'Neuren Pharmaceuticals Ltd',
Exchange: 'AU',
CurrencyCode: 'AUD',
CurrencyName: 'Australian Dollar',
CurrencySymbol: 'A$',
CountryName: 'Australia',
CountryISO: 'AU',
OpenFigi: 'BBG000CS0G08',
ISIN: 'NZNEUE0001S8',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: '2005-02-03',
InternationalDomestic: 'International',
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Neuren Pharmaceuticals Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 193 M
  • EBITDA 155 M
  • Earnings Per Share 0.93
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Neuren Pharmaceuticals Ltd Earnings via APIs

  • Latest Release 2024-08-27
  • EPS/Forecast NaN

Get Neuren Pharmaceuticals Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Neuren Pharmaceuticals Ltd latest news via APIs

Those who invested in Neuren Pharmaceuticals (ASX:NEU) three years ago are up 576%

The last three months have been tough on Neuren Pharmaceuticals Limited (ASX:NEU) shareholders, who have seen the share price decline a rather worrying 32%. But over three years the performance has be...

Neuren Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

Neuren Pharmaceuticals Limited (ASX:NEU) came out with its interim results last week, and we wanted to see how the business is performing and what industry forecasters think of the company following t...
Do you have any questions?
support@eodhistoricaldata.com